Schizophrenia: The drug deadlock (original) (raw)

The biology is too complicated. Pharma companies are quitting. Where are schizophrenia drugs going to come from?

References

1. Lieberman, J. A. et al. N. Engl. J. Med. 353, 1209-1223 (2005).
   Article CAS Google Scholar
2. Buchanan, R. W. et al. Schizophr. Bull. 31, 5-19 (2005).
   Article Google Scholar
3. Kirkpatrick, B., Fenton, W. S., Carpenter, W. T. Jr & Marder, S. R. Schizophr. Bull. 32, 214-219 (2006).
   Article Google Scholar
4. Steffanson, H. et al. Nature 455, 232-236 (2008).
   Article ADS Google Scholar

Download references

Related links

Rights and permissions

About this article

Cite this article

Abbott, A. Schizophrenia: The drug deadlock.Nature 468, 158–159 (2010). https://doi.org/10.1038/468158a

Download citation

• Published: 10 November 2010
• Issue Date: 11 November 2010
• DOI: https://doi.org/10.1038/468158a